Comparative in vitro susceptibility of a novel fluoroquinolone antibiotic candidate WFQ-228, levofloxacin, and moxifloxacin against Mycobacterium tuberculosis

Comparative in vitro susceptibility of a novel fluoroquinolone antibiotic candidate WFQ-228, levofloxacin, and moxifloxacin against Mycobacterium tuberculosis

Objective: WFQ-228 is a novel developed fluoroquinolone (FQ) displaying potent antimicrobial activity against various clinical isolates of pathogens, including FQ-resistant isolates. The aim was to comparatively analyze in vitro susceptibilities of WFQ-228, levofloxacin (LFX), and moxifloxacin (MFX)...

Full description

Bibliographic Details
Main Authors: Min Qiao, Weicong Ren, Haiping Guo, Fengmin Huo, Yuanyuan Shang, Yufeng Wang, Mengqiu Gao, Yu Pang
Format: Article
Language:English
Published: Elsevier 2021-05-01
Series:International Journal of Infectious Diseases
Subjects:
WFQ-228
Mycobacterium
gyrA
Susceptibility
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221003477

Internet

http://www.sciencedirect.com/science/article/pii/S1201971221003477

Similar Items